|
Market Analysis Reports of Levofloxacin Mesylate
|
Global Market Report of Levofloxacin mesylate (CAS 226578-51-4) December 2024
Beijing Double-Crane Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... ; antimicrobial drugs, such as ofloxacin and levofloxacin mesylate; and metformin hydrochloride for the ...
Benda Pharmaceutical, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... acute upper respiratory system infection; Levofloxacin Mesylate API, an antibiotic drug manufacture; Ribose ...
Wuhan Hiteck Biological Pharma Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... injection, thrombin freeze-dried powder, levofloxacin mesylate for injection, defibrase for injection ...
Zhejiang Jingxin Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... hydrochloride tablets, roxithromycin capsules, gatifloxacin mesylate and sodium chloride injection, and ... dosage forms; APIs, which consist of levofloxacin hemihydrate, ciprofloxacin HCL, ofloxacin, gatifloxacin ...
Neul Laboratories Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , Aripiprazole, Bosentan Monohydrate, Dabigatran Etexilate Mesylate, Deferasirox, Enalapril Maleate, Escitalopram Oxalate ... , Posaconazole, Propofol, Ropinirole Hydrochloride, Ticagrelor, Levofloxacin Hemihydrate and Ciprofloxacin Base. It caters ...
|
|
|